A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain

NCT01060254 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

31

Enrollment

INDUSTRY

Sponsor class

Stopped Logistic reasons associated with the FDA-imposed clinical hold.

Conditions

Cystitis, Interstitial
Urologic Diseases
Urinary Bladder Diseases
Cystitis

Interventions

DRUG: Placebo
DRUG: JNJ-42160443

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.